Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Arch Intern Med (2012) 5.56

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.27

Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.82

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing (2000) 3.35

Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen. Am J Med (2005) 2.63

Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) (1984) 1.83

Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ (2012) 1.68

A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation. Br J Haematol (1998) 1.63

Prediction of warfarin dose: why, when and how? Pharmacogenomics (2012) 1.09

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol (2011) 1.06

[Epidemiology, etiology and mechanism of atrial fibrillation]. Bull Acad Natl Med (2012) 0.85

Moving toward a more ideal anticoagulant: the oral direct thrombin and factor Xa inhibitors. Chest (2013) 0.79

Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med (2013) 5.34

Evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment. Am Heart J (2005) 0.75